Literature DB >> 8557390

First case of disseminated Mycobacterium avium infection following chemotherapy for childhood acute myeloid leukemia.

A Claass1, A Claviez, E Westphal, S Rüsch-Gerdes, R Schneppenheim.   

Abstract

A 14-year-old girl of Indian origin with acute myeloid leukemia (AML) is presented, who was diagnosed at the age of twelve. Antileukemic chemotherapy had to be discontinued after 6 weeks because of persistent high fever and the emergence of liver and spleen abscesses. Serologic and biopsy findings were consistent with disseminated candidiasis; however, a liver biopsy also revealed granulomatous lesions with caseous degeneration. No acid-fast bacilli could be detected. Upon antifungal treatment the patient's condition improved, but fever spells and high inflammatory blood parameters persisted. One year after the diagnosis of AML was established, Mycobacterium avium was cultured from bone marrow aspirates. The patient's cellular immunity was severely compromised at that time as reflected by the marked depression of T-lymphocyte counts, in particular of CD4-positive cells. HIV and other lymphotropic virus infections were subsequently excluded. After 5 months of specific treatment the patient recovered from mycobacterial infection and remains in first remission of AML. Opportunistic infections have rarely been diagnosed in oncologic patients to date, while data on T-cell function in AML is sparse. Fever of unknown origin should prompt the search for infectious agents unusual to date in this patient group.

Entities:  

Mesh:

Year:  1995        PMID: 8557390     DOI: 10.1007/bf01716291

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

Review 1.  Disseminated Mycobacterium avium complex in non-human immunodeficiency virus-infected pediatric patients.

Authors:  A B Stone; R L Schelonka; D M Drehner; D P McMahon; D P Ascher
Journal:  Pediatr Infect Dis J       Date:  1992-11       Impact factor: 2.129

2.  Treatment results of three consecutive German childhood AML trials: BFM-78, -83, and -87. AML-BFM-Group.

Authors:  J Ritter; U Creutzig; G Schellong
Journal:  Leukemia       Date:  1992       Impact factor: 11.528

3.  Peripheral blood T lymphocyte subpopulations in patients with tuberculosis and the effect of chemotherapy.

Authors:  M Singhal; J N Banavalikar; S Sharma; K Saha
Journal:  Tubercle       Date:  1989-09

4.  Prolonged defects of interleukin-2 production, responsiveness, and receptor expression in patients with acute lymphoblastic leukemia.

Authors:  M S Borzy; D Ridgway
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

5.  Catheter-related sepsis caused by Mycobacterium avium complex.

Authors:  R L Schelonka; D P Ascher; D P McMahon; D M Drehner; M R Kuskie
Journal:  Pediatr Infect Dis J       Date:  1994-03       Impact factor: 2.129

6.  T cell function in children with acute lymphoblastic leukaemia.

Authors:  K A Nash; G Mohammed; N Nandapalan; J Kernahan; R Scott; A W Craft; G L Toms
Journal:  Br J Haematol       Date:  1993-03       Impact factor: 6.998

7.  Cellular immunosuppression in children with acute lymphoblastic leukemia: effect of consolidation chemotherapy.

Authors:  Y Komada; S L Zhang; Y W Zhou; M Hanada; T Shibata; E Azuma; M Sakurai
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

  7 in total
  1 in total

Review 1.  Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.

Authors:  Stéphanie Boisson-Dupuis; Jacinta Bustamante; Jamila El-Baghdadi; Yildiz Camcioglu; Nima Parvaneh; Safaa El Azbaoui; Aomar Agader; Amal Hassani; Naima El Hafidi; Nidal Alaoui Mrani; Zineb Jouhadi; Fatima Ailal; Jilali Najib; Ismail Reisli; Adil Zamani; Sebnem Yosunkaya; Saniye Gulle-Girit; Alisan Yildiran; Funda Erol Cipe; Selda Hancerli Torun; Ayse Metin; Basak Yildiz Atikan; Nevin Hatipoglu; Cigdem Aydogmus; Sara Sebnem Kilic; Figen Dogu; Neslihan Karaca; Guzide Aksu; Necil Kutukculer; Melike Keser-Emiroglu; Ayper Somer; Gonul Tanir; Caner Aytekin; Parisa Adimi; Seyed Alireza Mahdaviani; Setareh Mamishi; Aziz Bousfiha; Ozden Sanal; Davood Mansouri; Jean-Laurent Casanova; Laurent Abel
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.